KERX +42.9% (forgot to put out alert yesterday) (announces Zerenex meets primary and all key secondary endpoints in Phase 3 long-term study as a treatment for Jyperphosphatemia; expects NDA with FDA in Q2 of 2013).
This stock has been on my trading list for a very long time, and is really paying off. Close Friday at $3.43. High pre-market price today is $5.25, testing the $5.42 high on 6-1-11. All technical's are on a buy signal as of 6 days ago when volume sky rocketed to the highest of the year. This is a message in increasing volume, and volume precedes price.
All material posted by langlui is purely my opinion and is not buy or sell recommendations. Do your DD, buy and sell based on that DD.